-
1
-
-
33745726470
-
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas
-
Catalaa I, Henry R, Dillon WP, Graves EE, McKnight TR, Lu Y et al. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 2006; 19: 463-75.
-
(2006)
NMR Biomed
, vol.19
, pp. 463-475
-
-
Catalaa, I.1
Henry, R.2
Dillon, W.P.3
Graves, E.E.4
McKnight, T.R.5
Lu, Y.6
-
2
-
-
0345254996
-
Glioma grading: Sensitivity, specificity, and predictive values of perfusion MRimaging and protonMRspectroscopic imaging compared with conventional MR imaging
-
Law M, Yang S,Wang H, Babb JS, Johnson G, Cha S et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MRimaging and protonMRspectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol 2003; 24: 1989-98.
-
(2003)
Am J Neuroradiol
, vol.24
, pp. 1989-1998
-
-
Law, M.1
Yang Swang, H.2
Babb, J.S.3
Johnson, G.4
Cha, S.5
-
3
-
-
0346097992
-
In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases
-
Fan G, Sun B, Wu Z, Guo Q, Guo Y. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004; 59: 77-85.
-
(2004)
Clin Radiol
, vol.59
, pp. 77-85
-
-
Fan, G.1
Sun, B.2
Wu, Z.3
Guo, Q.4
Guo, Y.5
-
4
-
-
20944450081
-
The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours
-
Fayed N, Modrego PJ. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours. J Neurooncol 2005; 72: 261-5.
-
(2005)
J Neurooncol
, vol.72
, pp. 261-265
-
-
Fayed, N.1
Modrego, P.J.2
-
5
-
-
0037307566
-
Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: Assessment of the value of the method
-
Walecki J, Tarasow E, Kubas B, Czemicki Z, Lewko J, Podgorski J et al. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. Acad Radiol 2003; 10: 145-53.
-
(2003)
Acad Radiol
, vol.10
, pp. 145-153
-
-
Walecki, J.1
Tarasow, E.2
Kubas, B.3
Czemicki, Z.4
Lewko, J.5
Podgorski, J.6
-
6
-
-
0026468277
-
Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance
-
Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992; 185: 675-82.
-
(1992)
Radiology
, vol.185
, pp. 675-682
-
-
Fulham, M.J.1
Bizzi, A.2
Dietz, M.J.3
Shih, H.H.4
Raman, R.5
Sobering, G.S.6
-
7
-
-
0036893356
-
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: Initial experience
-
Rabinov JD, Lee PL, Barker FG, Louis DN, Harsh GR, Cosgrove GR et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 2002; 225: 871-9.
-
(2002)
Radiology
, vol.225
, pp. 871-879
-
-
Rabinov, J.D.1
Lee, P.L.2
Barker, F.G.3
Louis, D.N.4
Harsh, G.R.5
Cosgrove, G.R.6
-
8
-
-
1642411835
-
Monitoring individual response to braintumour chemotherapy: Proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy
-
Lichy MP, Bachert P, Henze M, Lichy CM, Debus J, Schlemmer HP. Monitoring individual response to braintumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy. Neuroradiology 2004; 46: 126-9.
-
(2004)
Neuroradiology
, vol.46
, pp. 126-129
-
-
Lichy, M.P.1
Bachert, P.2
Henze, M.3
Lichy, C.M.4
Debus, J.5
Schlemmer, H.P.6
|